International consensus statement on allergy and rhinology: Allergic rhinitis–2023

SK Wise, C Damask, LT Roland, C Ebert… - International forum of …, 2023‏ - Wiley Online Library
Background In the 5 years that have passed since the publication of the 2018 International
Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (ICAR‐Allergic Rhinitis …

[HTML][HTML] Type 2 inflammation in asthma and other airway diseases

J Maspero, Y Adir, M Al-Ahmad… - ERJ open …, 2022‏ - publications.ersnet.org
Chronic inflammatory airway diseases, including asthma, chronic rhinosinusitis, eosinophilic
COPD and allergic rhinitis are a global health concern. Despite the coexistence of these …

Nomenclature of allergic diseases and hypersensitivity reactions: Adapted to modern needs: An EAACI position paper

M Jutel, I Agache, M Zemelka‐Wiacek, M Akdis… - Allergy, 2023‏ - Wiley Online Library
The exponential growth of precision diagnostic tools, including omic technologies, molecular
diagnostics, sophisticated genetic and epigenetic editing, imaging and nano‐technologies …

International consensus statement on allergy and rhinology: rhinosinusitis 2021

RR Orlandi, TT Kingdom, TL Smith… - International forum of …, 2021‏ - Wiley Online Library
I. Executive Summary Background The 5 years since the publication of the first International
Consensus Statement on Allergy and Rhinology: Rhinosinusitis (ICAR‐RS) has witnessed …

[HTML][HTML] Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials

P Gevaert, TA Omachi, J Corren, J Mullol, J Han… - Journal of Allergy and …, 2020‏ - Elsevier
Background Chronic rhinosinusitis with nasal polyps (CRSwNP) is characterized by IgE
hyperproduction and eosinophilic inflammation. The anti-IgE antibody, omalizumab, has …

ERCP-related adverse events: European Society of Gastrointestinal Endoscopy (ESGE) guideline

JM Dumonceau, C Kapral, L Aabakken… - …, 2020‏ - thieme-connect.com
Prophylaxis 1 ESGE recommends routine rectal administration of 100 mg of diclofenac or
indomethacin immediately before endoscopic retrograde cholangiopancreatography …

EUFOREA expert board meeting on uncontrolled severe chronic rhinosinusitis with nasal polyps (CRSwNP) and biologics: definitions and management

C Bachert, JK Han, M Wagenmann… - Journal of Allergy and …, 2021‏ - Elsevier
Uncontrolled severe chronic rhinosinusitis with nasal polyps (CRSwNP) is the most
bothersome phenotype of chronic rhinosinusitis; it is typically characterized by a type 2 …

[HTML][HTML] Chronic rhinosinusitis with nasal polyps and asthma

TM Laidlaw, J Mullol, KM Woessner, N Amin… - The Journal of Allergy …, 2021‏ - Elsevier
Patients with chronic rhinosinusitis with nasal polyps (CRSwNP) characterized by a type 2
immune signature often have severe and recurrent disease. Lower airway conditions such …

Endotypes of chronic rhinosinusitis: relationships to disease phenotypes, pathogenesis, clinical findings, and treatment approaches

A Kato, AT Peters, WW Stevens, RP Schleimer… - Allergy, 2022‏ - Wiley Online Library
Chronic rhinosinusitis (CRS) is a common clinical syndrome that produces significant
morbidity and costs to our health system. The study of CRS has progressed from an era …

Executive summary of EPOS 2020 including integrated care pathways.

WJ Fokkens, VJ Lund, C Hopkins, PW Hellings, R Kern… - Rhinology, 2020‏ - europepmc.org
The European Position Paper on Rhinosinusitis and Nasal Polyps 2020 is the update of
similar evidence based position papers published in 2005 and 2007 and 2012 (1-3). The …